Literature DB >> 33394290

Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.

Cheng Hang1, Chen Gong1, Yanfei Fang1, Long Chen1, Jianxin Zhu2.   

Abstract

Previous studies have shown aberrant expression of ubiquitin-specific protease 14 (USP14) in multiple malignancies, suggesting an important role of USP14 in tumorigenesis. However, the functional role of USP14 in pancreatic ductal adenocarcinoma (PDAC) has never been elucidated. In this study, we found that USP14 was remarkably upregulated in PDAC tissues compared with normal pancreatic tissues. Notably, Kaplan-Meier curves showed that high expression of USP14 predicted significantly worse prognosis in PDAC patients than low expression of USP14. To determine whether USP14 could regulate the proliferation, apoptosis and metastasis of PDAC cells, we knocked down endogenous USP14 or overexpressed exogenous USP14 in Panc-1 and BxPC-3 cells. Using MTT assays, colony formation analyses, flow cytometry assays, and cell invasion and migration assays, we found that knockdown of USP14 attenuated proliferation, induced apoptosis and restrained invasion and migration of PDAC cells. Overexpression of USP14 could enhance proliferation, prevent apoptosis and promote invasion and migration of PDAC cells. In addition, USP14 could regulate the expression of cyclin D1, PCNA and E-cadherin, three important carcinogenic factors, in PDAC cells. These findings suggest that USP14 might play an important role in promoting the tumorigenesis of PDAC and thus be a promising therapeutic target to prevent PDAC progression.

Entities:  

Keywords:  Metastasis; Pancreatic ductal adenocarcinoma (PDAC); Proliferation; USP14

Mesh:

Substances:

Year:  2021        PMID: 33394290     DOI: 10.1007/s10735-020-09934-0

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  30 in total

Review 1.  Pancreatic cancer: yesterday, today and tomorrow.

Authors:  Daniel Ansari; Bobby Tingstedt; Bodil Andersson; Fredrik Holmquist; Christian Sturesson; Caroline Williamsson; Agata Sasor; David Borg; Monika Bauden; Roland Andersson
Journal:  Future Oncol       Date:  2016-06-01       Impact factor: 3.404

2.  USP14 activation promotes tumor progression in hepatocellular carcinoma.

Authors:  Gang Huang; Limei Li; Weiping Zhou
Journal:  Oncol Rep       Date:  2015-09-21       Impact factor: 3.906

3.  Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14.

Authors:  Min Hu; Pingwei Li; Ling Song; Philip D Jeffrey; Tatiana A Chenova; Keith D Wilkinson; Robert E Cohen; Yigong Shi
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

Review 4.  Deubiquitinase inhibition as a cancer therapeutic strategy.

Authors:  Padraig D'Arcy; Xin Wang; Stig Linder
Journal:  Pharmacol Ther       Date:  2014-11-06       Impact factor: 12.310

Review 5.  Improving theranostics in pancreatic cancer.

Authors:  Jeremy King; Michael Bouvet; Gagandeep Singh; John Williams
Journal:  J Surg Oncol       Date:  2017-05-17       Impact factor: 3.454

6.  A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

Authors:  Justin Lamb; Sridhar Ramaswamy; Heide L Ford; Bernardo Contreras; Robert V Martinez; Frances S Kittrell; Cynthia A Zahnow; Nick Patterson; Todd R Golub; Mark E Ewen
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

7.  USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer.

Authors:  Soley Bayraktar; Angelica M Gutierrez Barrera; Diane Liu; Lajos Pusztai; Jennifer Litton; Vicente Valero; Kelly Hunt; Gabriel N Hortobagyi; Yun Wu; Fraser Symmans; Banu Arun
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.

Authors:  Brajesh P Kaistha; Anja Krattenmacher; Johannes Fredebohm; Harald Schmidt; Diana Behrens; Miriam Widder; Thilo Hackert; Oliver Strobel; Jörg D Hoheisel; Thomas M Gress; Malte Buchholz
Journal:  Oncotarget       Date:  2017-08-03

10.  USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.

Authors:  Ying Fu; Gang Ma; Guolong Liu; Bin Li; Hui Li; Xishan Hao; Liren Liu
Journal:  Cancer Med       Date:  2018-09-17       Impact factor: 4.452

View more
  3 in total

1.  A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.

Authors:  Chunle Zhao; Jun Gong; Yu Bai; Taoyuan Yin; Min Zhou; Shutao Pan; Yuhui Liu; Yang Gao; Zhenxiong Zhang; Yongkang Shi; Feng Zhu; Hang Zhang; Min Wang; Renyi Qin
Journal:  Cell Death Differ       Date:  2022-07-29       Impact factor: 12.067

Review 2.  The role of ubiquitination and deubiquitination in tumor invasion and metastasis.

Authors:  Shuangze Han; Ruike Wang; Yangnan Zhang; Xiaoying Li; Yu Gan; Feng Gao; Pengfei Rong; Wei Wang; Wei Li
Journal:  Int J Biol Sci       Date:  2022-03-06       Impact factor: 6.580

3.  The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.

Authors:  Jian Lei; Xiaoliu Liu; Wei Liu; Yun Zhang; Zhihong Liu
Journal:  Ann Transl Med       Date:  2021-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.